Technology at the cutting edge in the labs today takes a shorter time to mature and commercialize. Companies need funds to continue their research and improve their products and service offerings which are then rolled out faster for cash flow generation and early market dominance. Inevitably, new products and software that are not directly affecting human health, like drugs and treatments, may be less regulated, thoroughly tested and inherited some imperfections. Companies would rely on their customers' and early adopters' feedback to correct these minor defects or discontinue if the market response is not good. That would be more economical than perfecting a product before launch.
If the impact of the product failures is not severe or frequent, compliance, regulations and insurance will remain slow to react and adopt a wait-and-see position to evaluate when larger losses come along. As a result, many new technologies and products may not be able to find competitive insurance products, and the stakeholders are not adequately protected against losses and liabilities. Some examples are:
It is worth noting the new technologies emerging in the fields of:
Do I trust the Chinese software that just locked me up in a metal box with wheels? What recourse do I have against cyber attacks on AVs?
With more digital power, comes more cybersecurity. It isn't as simple as installing a lock or security camera. Yet the risk is real and the consequences devastating.
AI the Super Boy has yet to achieve its immense potential. The big brothers are fighting to establish global dominance over us. What can the boys achieve with rockets in our hands --
Superman or Homelander?